Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - vi polysaccharide, of salmonella, typhi - solution for injection - vi polysaccharide of salmonella typhi 25 µg - vaccines

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - salmonella typhimurium cn5988 (inactivated); salmonella brandenburg 1br 3684 (inactivated); salmonella bovis morbificans cn1412 (inactivated); salmonella typhimurium cn6141 (inactivated); salmonella hindmarsh cn 5989 (inactivated) - salmonella typhimurium cn5988 (inactivated) 0 vaccine; salmonella brandenburg 1br 3684 (inactivated) 0 vaccine; salmonella bovis morbificans cn1412 (inactivated) 0 vaccine; salmonella typhimurium cn6141 (inactivated) 0 vaccine; salmonella hindmarsh cn 5989 (inactivated) 0 vaccine - vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - mycoplasma synoviae strain ms-h vaccine, living - misc. aural, ophthalmic, oro/naso pharyngeal - mycoplasma synoviae strain ms-h vaccine, living vaccine-general active 105.7 ccu/dose - immunotherapy - poultry broilers (meat for human consum) | poultry layers (eggs for human consump) | poultry pullets (growing chook) | breeding - airsacculitis | chronic respiratory disease | infectious synovitis | vaccine | equine rotavirus | ms

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - vaccine - salmonella spp. - vaccine

Canada - English - Health Canada

sanofi pasteur limited - salmonella typhi vi capsular polysaccharide vaccine; hepatitis a vaccine, inactivated - solution - 25mcg; 160unit - salmonella typhi vi capsular polysaccharide vaccine 25mcg; hepatitis a vaccine, inactivated 160unit - vaccines

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r

United States - English - NLM (National Library of Medicine)

emergent travel health inc. - salmonella typhi ty21a live antigen (unii: 0mzi008m96) (salmonella typhi ty21a live antigen - unii:0mzi008m96) - salmonella typhi ty21a live antigen 6000000000 [cfu] - vivotif (typhoid vaccine live oral ty21a) is indicated for immunization of adults and children greater than 6 years of age against disease caused by salmonella typhi . routine typhoid vaccination is not recommended in the united states of america. selective immunization against typhoid fever is recommended for the following groups: 1) travelers to areas in which there is a recognized risk of exposure to s. typhi , 2) persons with intimate exposure (e.g. household contact) to a s. typhi carrier, and 3) microbiology laboratorians who work frequently with s. typhi (7). there is no evidence to support the use of typhoid vaccine to control common source outbreaks, disease following natural disasters or in persons attending rural summer camps. not all recipients of vivotif will be fully protected against typhoid fever. vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms. the vaccine will not afford protection against species of salmonella other than salm

United States - English - NLM (National Library of Medicine)

apotheca company - salmonella enterica subsp. enterica serovar enteritidis (unii: y3v16d4pv4) (salmonella enterica subsp. enterica serovar enteritidis - unii:y3v16d4pv4) - salmonella enterica subsp. enterica serovar enteritidis 30 [hp_x] in 1 ml - indications:   to be used according to standard homeopathic indications. indications: to be used according to standard homeopathic indications.

France - English - HMA (Heads of Medicines Agencies)

lohmann animal health & co. - salmonella enteritidis 100000000 iu, salmonella typhimurium 100000000 iu - oral lyophilisate - chicken food - salmonella

Austria - English - HMA (Heads of Medicines Agencies)

lohmann animal health & co. - salmonella enteritidis 100000000 iu, salmonella typhimurium 100000000 iu - oral lyophilisate - chicken food - salmonella